Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection

AIDS
Elena ChiappiniItalian Register for HIV Infection in Children

Abstract

To investigate the impact of early versus deferred combined antiretroviral treatment (ART) in asymptomatic or moderately symptomatic [Centers for Disease Control and Prevention (CDC) category N, A or B] infants with perinatal HIV-1 infection. A multi-centre nationwide case-control study was conducted. Data from 30 infants treated with combined ART with three or more drugs before 6 months of age were compared with data from 103 infants starting ART with three or more drugs after 6 months of age. The median follow-up time was 4.1 years (range, 1.0-6.5 years). No difference was evident in the first available viral load and CD4 T-lymphocyte percentage between the two groups of children. Early-treated infants showed significantly lower viral loads than infants receiving deferred treatment at all the follow-up periods. A higher proportion of early-treated infants than infants receiving deferred treatment (73.3% versus 30.1%; P < 0.0001) reached an undetectable viral load. Higher CD4 T-lymphocyte percentages were found in early-treated infants at 13-24 (P < 0.0001), 25-36 (P < 0.0001), and 37-48 (P = 0.003) months of age. No early-treated infant versus 20 of 103 (19.4%) infants receiving deferred ART (P = 0.02) showed a CD4 T-lymphocy...Continue Reading

References

Aug 17, 2002·The Pediatric Infectious Disease Journal·Albert FayeUNKNOWN French Perinatal Study
Jan 23, 2003·Pediatric Research·Slavador ResinoMaria Angeles Muñoz-Fernández
Sep 10, 2003·Journal of Clinical Immunology·Salvador ResinoM Angeles Muñoz-Fernandez
Nov 25, 2003·Lancet·David Dunn, UNKNOWN HIV Paediatric Prognostic Markers Collaborative Study Group
May 25, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sigall Kassutto, Eric S Rosenberg

❮ Previous
Next ❯

Citations

Nov 21, 2008·The New England Journal of Medicine·Avy ViolariUNKNOWN CHER Study Team
Dec 27, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tessa GoetghebuerUNKNOWN European Infant Collaboration Group
May 29, 2007·The Pediatric Infectious Disease Journal·Edmore MarindaUNKNOWN ZVITAMBO Study Group
Feb 19, 2008·The Pediatric Infectious Disease Journal·Mireille HenryCatherine Tamalet
Mar 31, 2010·The Pediatric Infectious Disease Journal·Gabriela MarónPatricia M Flynn
Feb 6, 2009·AIDS·Tessa GoetghebuerUNKNOWN European Infant Collaboration group
Feb 8, 2011·AIDS·Ellen G ChadwickUNKNOWN International Pediatric Adolescent Clinical Trials Group (IMPAACT) P1030 Team
Aug 4, 2011·European Journal of Medical Research·Sujal GhoshH J Laws
May 7, 2009·Future Microbiology·Christy A Beneri, Sharon Nachman
Sep 21, 2007·Current Infectious Disease Reports·Elisa A d'OulxPier-Angelo Tovo
May 29, 2014·AIDS Research and Human Retroviruses·Cristina B HoferRohan Hazra
Jun 2, 2010·Infection·C GiaquintoUNKNOWN Italian Paediatric HIV Infection Working Group
Feb 11, 2014·Expert Review of Anti-infective Therapy·Stephanie Shiau, Louise Kuhn
Jun 30, 2009·Expert Opinion on Pharmacotherapy·Dimitri Van der LindenRobert Colebunders
Nov 3, 2009·Antiviral Research·Martina PenazzatoCarlo Giaquinto
Jan 16, 2007·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·A Faye
Dec 6, 2008·Tropical Medicine & International Health : TM & IH·Peter IliffJean Humphrey
Nov 5, 2013·Developmental Medicine and Child Neurology·Nelleke G LangerakBarbara Laughton
Mar 31, 2015·AIDS Research and Human Retroviruses·Bhavna H ChohanGrace John-Stewart
Jul 15, 2015·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Mireille PorterBrian Eley
Apr 22, 2015·The Pediatric Infectious Disease Journal·Maurizio de MartinoElena Chiappini
Apr 8, 2015·AIDS·Paul KrogstadUNKNOWN Pediatric HIVAIDS Cohort Study, IMPAACT 219C, and NICHD International Site Development Initiative (NISDI) Investigators
Sep 16, 2016·Maternal and Child Health Journal·Emily R SmithAnnelies Van Rie
Nov 4, 2017·Expert Review of Clinical Pharmacology·Louise Kuhn, Stephanie Shiau
Jul 2, 2015·International Journal of Palliative Nursing·Hanneke Brits, Gina Joubert
Aug 19, 2007·Pediatric Annals·Ana M Alvarez, Mobeen H Rathore
Nov 13, 2019·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Sara Domínguez-RodríguezPablo Rojo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Albert FayeFrench Perinatal Study Group
The New England Journal of Medicine
Katherine LuzuriagaPACTG 356 Investigators
© 2021 Meta ULC. All rights reserved